Interleukin Genetics Inc. (ILGN) and University of North Carolina Publish Genetic Factors Predictive of Progression of Knee Osteoarthritis
5/8/2013 10:47:50 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) announced today the online publication in Osteoarthritis and Cartilage of a study with investigators at the Thurston Arthritis Research Center of the University of North Carolina entitled, “IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort.”
Help employers find you! Check out all the jobs and post your resume.